NovackG.D.Pipeline: the accelerated drug approval. Ocul. Surf. 8:205–207, 2010.
2.
ChenE.Y., RaghunathanV., and PrasadV.An overview of cancer drugs approved by the US Food and Drug Administration based on the surrogate end point of response rate. JAMA Intern. Med. 179:915–921, 2019.
3.
LoftusP.Fast-track drug approval, designed for emergencies, is now routine. Wall Street J. July 5, 2019.
4.
PillerC.FDA enforcement actions plummet under Trump. Science. 365:12–13, 2019.
5.
McKayB.When routine eye surgery leads to debilitating pain. Wall Street J. July 1, 2019.
